________________________________________________________________________________________________________________________________

(C) Wolf G Kroner 2012 - Prof. Sadao NagaokaImproving the IP System on a global scale:
A view from Japan

February 2012. Prof. Sadao Nagaoka dedicates his academic work to the effects of intellectual property (IP) rights on R&D policy as well as the design of competition and trade policies. His work is influential in shaping the political framework for innovation in Japan. In the exclusive interview with B2Bioworld he describes barriers to innovation with examples from Japan’s life science sector. He outlines his role as Member of EPO’s advisory board, and offers insights about how and what the world’s major IP systems of Japan, Europe and the United States might learn from each other. Trends for biotech start-ups in Japan, an overview on its examination request system (including fast track) and expected impact of the Fukushima nuclear disaster on bio-prospecting.

If you like to read this article, you can purchase it now

Please notice, when purchasing articles you agree to B2Bioworld's Terms and Conditions

Read Now - Please select your license (Prices incl. 7% VAT)

Article free of advertisement - 8 pages
- Includes figures on Japanese biotech startups 1999-2009, use of fast examination track 1988-2005, the current examination request workflow, and other hard facts about the patent system in Japan

Full Company License enquire here

Back to section

Related Editorial Articles

Teeth to the Convention on Biological Diversity
Christian Wichard, Deputy Director General of WIPO on its role in enforcing compliance with access and benefit sharing requirements

Easier Access to Patent Claims Encoded in Chinese
EPO catalyzes innovation of intercontinental IP systems. Questions about Russia’s intentions

Resolving the innovation paradox
Günter von Au, Board Member Clariant AG and past President of Süd-Chemie

Patenting Stem Cells – Behind the Front Stages
The patentability of stem cells is of continuing debate. The article outlines the legal approach to stem cells as it informs solving juridical problems

The Global Dimension of EU Health and Food Policies
Paola Testori-Coggi, Director-General for Health and Consumers, European Commission

Prospects of Enzyme Engineering and Biofuels Markets in Russia
Vladimir O. Popov, Director Bach Institute of Biochemistry, Moscow

Plants are Nature’s Best Chemists
On application fields from tyres, functional food, to platform chemicals

Custom Sequencing Markets
Worldwide evolution of the market and upcoming business opportunities. B2Bioworld asked Bruno Poddevin, Eurofins Genomics Services.